Financials
Financial year 2024
Worth noting
- The team shrank two years in a row.
Revenue
€ 303.4 million
▼ 52% vs 2023
Profit
Healthy€ 47.8 million
▼ 82% vs 2023
Debts
Low€ 1,197.1 million
▼ 20% vs 2023
Lakefront Biotherapeutics from Mechelen, company number BE0466460429, closed financial year 2024 with a result of € 47.8 million after tax. For that financial year Lakefront Biotherapeutics recorded revenue of € 303.4 million and equity of € 2,829.5 million. Compared with financial year 2023, the result moved from € 271.3 million to € 47.8 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 22, 2025.
What happened at Lakefront Biotherapeutics?
What happened at Lakefront Biotherapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Andrew Dickinson stepped down as director. NBB
- Susanne Schaffert stepped down as director. NBB
- Elisabeth Svanberg stepped down as director. NBB
- Simon Sturge stepped down as director. NBB
- Linda Higgins stepped down as director. NBB
- Peter Guenter stepped down as director. NBB
- Oleg Nodelman stepped down as director. NBB
- Stoffels IMC BV stepped down as director. NBB
In short
From € 92.7 million loss in 2021 to € 47.8 million profit in 2024.
Best year ever: 2023, with € 271.3 million profit.
Pays suppliers within 89 days on average.
A new publication or filing at Lakefront Biotherapeutics? We notify you, reason included.
Follow Lakefront BiotherapeuticsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Galapagos U.K. ltd, 100% of Galapagos Holding Pte Ltd, 100% of Galapagos Real Estate Belgium, 100% of Galapagos US Holding Inc, 100% of Galapagos GmbH and 100% of Galapagos Real Estate Netherlands B.V. itself.
Directors
According to the 2024 annual accounts
Oleg Nodelman
Director
since 2024 · until 2026
Linda Higgins
Director
since 2023 · until 2027
Chairman of the board · represented by Paul Stoffels
since 2022 · until 2026
Peter Guenter
Director
since 2023 · until 2027
Susanne Schaffert
Director
since 2023 · until 2028
Elisabeth Svanberg
Director
since 2024 · until 2028
Jérôme Contamine
Director
since 2022 · until 2026
Simon Sturge
Director
since 2023 · until 2028
Andrew Dickinson
Director
since 2024 · until 2028
Establishments
Establishment units
Physical locations of this company
Schaliënhoevedreef 20T
2800 Mechelen
Generaal De Wittelaan 11
2800 Mechelen
Active since 19 August 1999
Schaliënhoevedreef 20 box T
2800 Mechelen
Active since 1 January 2018
Generaal De Wittelaan 21
2800 Mechelen
Active since 1 January 2018
Schaliënhoevedreef 20 box F
2800 Mechelen
Active since 22 January 2020
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 52 companies are registered at this address.
FINAL TOUCH
Hal Leonard Europe
€ 148,146 gross margin · 2024
Whiterock
€ -5,199 gross margin · 2025
ASTERION BELGIUM
€ 3.3 million revenue · 2024
Curium Belgium
€ 7.8 million revenue · 2025
+47 more
Details
- Company number
- 0466.460.429
- VAT number
- BE 0466.460.429
- Registered office
- Schaliënhoevedreef 20T, 2800 Mechelen
- Names & denominations
- Lakefront Biotherapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 1999
- Peppol
- Active · Active since 11 Dec 2025
- Activities · NACE
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied